Cannabis Suisse Corp (CSUI) Q2 2026 Earnings Report

Cannabis Suisse Corp (CSUI) reports a structurally weak operating performance in QQ2 2026 with negligible revenue and a material operating loss, masked by a sizable non-operating income line that yields a positive net income of $22.4k. The quarter shows an operating loss of $74.98k and an EBITDA of $-73.92k, driven by $74.98k in operating expenses (including $73.92k of G&A) and only $1.06k in cost of revenue. A substantial non-operating item of $97.37k income more than offsets the operating shortfall to produce income before tax of $22.39k and net income of $22.39k, translating to an EPS of $0.0003 on 70.68 million weighted-average shares (diluted 205.88 million). While the headline net income is positive, it is not reflective of core operations and raises questions about earnings quality.

From a cash flow and balance sheet perspective, CSUI remains cash-strapped and levered. Operating cash flow is negative at $-20.31k and free cash flow is $(20.68k). The company ended the period with only $2.63k in cash and cash equivalents. Total assets amount to $510k, while total liabilities are $2,275k, yielding negative stockholders’ equity of $(1.77) million. Long-term debt stands at $1.88 million and short-term debt at $241.8k, with net debt around $(2.12) million. The current ratio is ~0.19x and the quick ratio is about 0.01x, signaling severe liquidity stress and limited near-term cushion. The quarterly metrics imply a continuation of cash burn unless financial and operational reform is undertaken.

Overall, the QQ2 2026 results underscore a high-risk, high-leverage profile with outsized dependence on non-operating income to post a quarterly gain. In the absence of meaningful top-line growth or debt restructuring, the investment thesis remains cautious.”